Istanbul Medipol University

Research Center for Regenerative and Restorative Medicine (REMER)

 

Hakan Cangül

The Research Center for Regerenative and Restorative Medicine (REMER) is a newly built $50M-world class biomedical research facility within the Istanbul Medipol University funded by the Ministry of Development (TR). It provides access to state-of-the-art laboratory accommodation with the latest top-of-the-range technology and equipment (details available on the web-site). Currently there are 21 senior academic staff and 76 research fellows, PhD students and technicians within the Center. There is a stimulating mix of clinical and basic scientists investigating the human physiology, pathogenesis of diseases and novel therapeutical approaches using a wide range of methodologies. Core facilities include: (i) Cell Culture and Sorter Lab, (ii) Molecular Biology and Histology, (iii) Proteomics, (iv) Genomics, (v) Bioinformatics, (vi) Advanced Microscopy (vii) Dental Research and Biomechanics, (viii) Pharmaceutical Chemistry and Pharmacognosy, (ix) Electrophysiology and Optogenetics, (x) Brain Research and Microsurgery, (xi) Analytical Chemistry, and (xii) Animal Facilities.

Medipol Health Group also owns a five-hospital chain affliated with the University. The hospital chain has a capacity of 1000 beds and 5000 daily out-patient registrations in total. This sizable capacity facilitates the recruitment of patients into research projects. Prof Cangul has ongoing contacts with key clinicians in these hospital including cardiologists, who are also affliated with the University, and they are keen to collaborate with him in his area of research.

This project is an analytic platform to deliver genetic‐based personalized care in Cardiovascular Diseases. It will impact health-based risk and cost of care for individuals in real-time. In addition, it will enable physicians, hospitals, health networks, health insurance companies, and others involved in population management to become predictive‐first.

Expertise

Personalised Medicine for Heart: Integration of clinical, genetic and life-style information for risk assessment, tailored prevention and therapy of heart diseases.

Interested in collaborating on

We seek expertise in the areas below matched to the tasks of the project:

  1. Designate the Participating Physicians and Study Coordinator
  2. Select the Participating Patients
  3. Patient Consultation
  4. Study Coordinator Enrolls the Patients
  5. Collect Saliva Sample For Genotyping
  6. Order Lab work 
  7. Genotype Analysis & Results
  8. OMICS Data (trancriptomics, proteomics, metabolomics, epigenomics, etc)
  9. Enter Patient’s Lab & Clinical Data
  10. Secure Data Integration 
  11. Risk & Recommendation Platforms
  12. Present Disease Risk Assessment

Website
hcangul@medipol.edu.tr

Kavacık Mah. Ekinciler Cad. No.19 Kavacık Kavsagı
Beykoz 34810 Istanbul
Turkey